Delivery Order SPE2DR25D3013-SPE2DR26F6U7P
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,123.04 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's broader indefinite delivery vehicle with the DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,080.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,526.66 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on November 25, 2025, with completion scheduled for November 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Kerendia 10 mg tablets in a 30-count package with a ceiling value of $14,581.71 under firm fixed pricing. This non-set-aside delivery order, due for completion by December 2, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a $2,212.01 delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,538.36 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a specific product delivery under...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6U7PDelivery Order
The Defense Logistics Agency awarded a $2,337.94 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 10 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive portfolio of pharmaceuticals and medical supplies to support military healthcare systems and other government agencies. The company's federal contracting history demonstrates consistent capability to fulfill diverse medical supply requirements through competitively awarded transactions, supporting Defense Health Agency operations and other federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/11/25 |